Publicacións en colaboración con investigadores/as de University of Bordeaux (2)

2022

  1. A scoring system for AML patients aged 70 years or older, eligible for intensive chemotherapy: a study based on a large European data set using the DATAML, SAL, and PETHEMA registries

    Blood Cancer Journal, Vol. 12, Núm. 7

  2. Long-term survival after intensive chemotherapy or hypomethylating agents in AML patients aged 70 years and older: a large patient data set study from European registries

    Leukemia, Vol. 36, Núm. 4, pp. 913-922